- cafead May 12, 2023 at 12:12: PM
via As GSK's former consumer health unit Haleon nears its one-year mark of independent operations, its former parent company is shedding 240 million shares.
Since Haleon’s July 2022 demerger, GSK has kept a 12.94% stake in the consumer health company. But in a statement this week, GSK said it's selling 240 million shares, or a 2.5% stake, in the company. The company plans to sell the shares to institutional investors at an undisclosed price.
article source
Since Haleon’s July 2022 demerger, GSK has kept a 12.94% stake in the consumer health company. But in a statement this week, GSK said it's selling 240 million shares, or a 2.5% stake, in the company. The company plans to sell the shares to institutional investors at an undisclosed price.
article source